Close Menu

NEW YORK (GenomeWeb) – Japanese genetic research and testing firm Genesis Healthcare announced today that it has completed the sale of ¥1.5 billion ($13.8 million) of newly issued shares to Rakuten.

In connection with the transaction, Rakuten Chairman and CEO Hiroshi Mikitani will join Genesis' board as an external director.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.


Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Sponsored by

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 


This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.